- Home
- PEPG vs OPRX Comparison
PEPG vs OPRX Comparison
Compare PEPG & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- OPRX
- Stock Information
- Founded
- PEPG 2018
- OPRX 2006
- Country
- PEPG United States
- OPRX United States
- Employees
- PEPG N/A
- OPRX N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- OPRX Business Services
- Sector
- PEPG Health Care
- OPRX Consumer Discretionary
- Exchange
- PEPG Nasdaq
- OPRX Nasdaq
- Market Cap
- PEPG 317.6M
- OPRX 380.6M
- IPO Year
- PEPG 2022
- OPRX N/A
- Fundamental
- Price
- PEPG $4.91
- OPRX $16.02
- Analyst Decision
- PEPG Strong Buy
- OPRX Buy
- Analyst Count
- PEPG 6
- OPRX 8
- Target Price
- PEPG $9.17
- OPRX $12.31
- AVG Volume (30 Days)
- PEPG 676.6K
- OPRX 309.1K
- Earning Date
- PEPG 11-06-2025
- OPRX 11-06-2025
- Dividend Yield
- PEPG N/A
- OPRX N/A
- EPS Growth
- PEPG N/A
- OPRX N/A
- EPS
- PEPG N/A
- OPRX 0.00
- Revenue
- PEPG N/A
- OPRX $109,506,000.00
- Revenue This Year
- PEPG N/A
- OPRX $17.92
- Revenue Next Year
- PEPG N/A
- OPRX $10.91
- P/E Ratio
- PEPG N/A
- OPRX $8,705.11
- Revenue Growth
- PEPG N/A
- OPRX 24.18
- 52 Week Low
- PEPG $0.88
- OPRX $3.78
- 52 Week High
- PEPG $6.85
- OPRX $22.25
- Technical
- Relative Strength Index (RSI)
- PEPG 56.79
- OPRX 37.60
- Support Level
- PEPG $4.05
- OPRX $14.81
- Resistance Level
- PEPG $4.89
- OPRX $16.84
- Average True Range (ATR)
- PEPG 0.40
- OPRX 1.45
- MACD
- PEPG -0.07
- OPRX -0.56
- Stochastic Oscillator
- PEPG 51.90
- OPRX 15.73
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.